bluebird bio, Inc.: revenue

What this measure means

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Exact concept: us-gaap:Revenues. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• bluebird bio, Inc.: total assets
• bluebird bio, Inc.: total liabilities
• bluebird bio, Inc.: stockholders equity
• bluebird bio, Inc.: cash and cash equivalents
• bluebird bio, Inc.: net income or loss
• bluebird bio, Inc.: operating cash flow
• bluebird bio, Inc.: capital expenditure payments
• bluebird bio, Inc.: contract revenue excluding tax
• bluebird bio, Inc.: financing cash flow
• bluebird bio, Inc.: investing cash flow
• bluebird bio, Inc.: retained earnings or deficit
• bluebird bio, Inc.: basic weighted-average shares
• bluebird bio, Inc.: diluted weighted-average shares
• bluebird bio, Inc.: basic earnings per share
• bluebird bio, Inc.: diluted earnings per share
• bluebird bio, Inc.: income tax expense or benefit
• bluebird bio, Inc.: net property, plant and equipment
• bluebird bio, Inc.: share-based compensation expense
• bluebird bio, Inc.: operating income or loss
• bluebird bio, Inc.: current assets
• bluebird bio, Inc.: current liabilities
• bluebird bio, Inc.: current accounts payable
• bluebird bio, Inc.: goodwill carrying amount
• bluebird bio, Inc.: net finite-lived intangible assets
• bluebird bio, Inc.: operating expenses
• bluebird bio, Inc.: net inventory
• bluebird bio, Inc.: gross profit
• bluebird bio, Inc.: cost of revenue
• bluebird bio, Inc.: selling, general and administrative expense
• bluebird bio, Inc.: research and development expense
• bluebird bio, Inc.: common shares outstanding
• bluebird bio, Inc.: cash including restricted cash
• bluebird bio, Inc.: additional paid-in capital
• bluebird bio, Inc.: accumulated other comprehensive income or loss
• bluebird bio, Inc.: operating lease right-of-use asset
• bluebird bio, Inc.: operating lease liability
• bluebird bio, Inc.: gross property, plant and equipment
• bluebird bio, Inc.: accumulated depreciation on property, plant and equipment
• bluebird bio, Inc.: net intangible assets excluding goodwill
• bluebird bio, Inc.: other noncurrent assets
• bluebird bio, Inc.: other noncurrent liabilities
• bluebird bio, Inc.: prepaid expenses and other current assets
• bluebird bio, Inc.: current contract liabilities
• bluebird bio, Inc.: pre-tax income or loss from continuing operations
• bluebird bio, Inc.: profit or loss including noncontrolling interests
• bluebird bio, Inc.: comprehensive income or loss
• bluebird bio, Inc.: net income available to common stockholders
• bluebird bio, Inc.: general and administrative expense
• bluebird bio, Inc.: depreciation, depletion and amortization
• bluebird bio, Inc.: amortization of intangible assets
• bluebird bio, Inc.: other nonoperating income or expense
• bluebird bio, Inc.: nonoperating income or expense
• bluebird bio, Inc.: interest paid, net
• bluebird bio, Inc.: income taxes paid, net
• bluebird bio, Inc.: proceeds from issuing common stock
• bluebird bio, Inc.: operating lease payments
• bluebird bio, Inc.: change in inventories
• bluebird bio, Inc.: change in accounts payable

Inspect the source

Entity

bluebird bio, Inc. / CIK 0001293971

Captured

2026-09-21T17:19:03.388Z

SEC response SHA-256

858d78d54f5bae3df00559b64af5a3aba62be12d2317b727228e8ddef2ef50ea

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001293971.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))